New data from the ENHANCE Ph 3b study show rapid 30-minute infusions are well tolerated in patients with #RMS. Check out the data: bit.ly/4gmEMrs – #TGTX #ECTRIMS2024 starts today #MS #FearlessForPatients
TG Therapeutics, Inc.的动态
最相关的动态
-
The second blog in URC Senior Portfolio Director Ersin Topcuoglu’s “Introducing New Tech to Defeat TB” series is live. This time, he discusses the implications of new technology for patients with drug-resistant TB. Read the blog: https://bit.ly/4f5sZ0e #DRTB #HealthIsSecurity
要查看或添加评论,请登录
-
"Ever wondered how the EDAN i15 ABG Analyser works??Then this is a must read! ?We'll walk you through the fascinating journey from sample insertion to result generation. ?Get ready to unravel the mysteries of this game-changing device and gain a deeper appreciation for its role in modern healthcare. Join us on this exploration of innovation and discover what makes the EDAN i15 ABG Analyzer tick!? ?Call?9444406059 to book a slot and?get a free consultation " More details :?https://surl.li/rnslr #clinicalautomationservices?#medicaldiagnostics?#edani15?#diagnosticequipment?#diagnostics ?#diagnostictools?#diagnosis?#diagnostic?#diagnose?#medicaldiagnosticequipment
要查看或添加评论,请登录
-
Strengthening outcomes through clinical evidence is key for all #PROTEOR innovations. #SYNSYS demonstrates 92% greater flat-foot time on the ground for greater stability—with one foot in total contact during descent of a slope or stairs. Read study at https://lnkd.in/g85v-AiN
要查看或添加评论,请登录
-
Using #dPCR platforms to detect COVID-19 as an example, differences in partitioning methods between multiple platforms can lead to data bias. Even within the same platform, variations in environmental factors, different operators, or batch differences in consumables can cause data discrepancies. Therefore, it is crucial to establish a standardized criterion for data interpretation. Sniper Medical Technologies https://lnkd.in/gAAHDM69
要查看或添加评论,请登录
-
Updates from an international multidisciplinary working group led to the expansion of #TARE #Y90 recommendations to apply to 5 common clinical scenarios in patients with #HCC View the Dosimetry Steering Committee recommendations here: https://bit.ly/3NzjI3O #LiverCancerAwarenessMonth Safety:?https://bit.ly/3tAbBIu
要查看或添加评论,请登录
-
Check out this new #MultipleSclerosis publication utilizing TriNetX! The investigators found the Random Forest (RF) model better than traditional regression models for treatment selection in MS patients. Read the full text: https://ow.ly/o4pz30sBbAS #MachineLearning #TreatmentModeling
要查看或添加评论,请登录
-
A systematic review of the influence of ciNPWT on scarring found decreased scar width and improved patient and observer-reported scar satisfaction: https://lnkd.in/dnNhgj2 #GMIScience #GMIPlastics
要查看或添加评论,请登录
-
?? Tired of lab labyrinths in #MolecularTesting? Simplify your #dPCR workflow with #QIAcuityDx. Click right to learn why you’re clinical lab will love it. Learn more ?? https://lnkd.in/eEFTaU9w
要查看或添加评论,请登录
-
US HCPs: Faced with an extremely difficult arch and tortuous ICA, the team used #BMX96 and an appropriately sized #RED72 with #SENDit to reach the proximal M1 achieving a first pass, TICI 3 in 7 minutes—setting a LAB RECORD! A textbook example of S-BAT in action. Well done, Dr. Park and team. Rx only. Risk: peninc.info/risk Clinical results may vary
要查看或添加评论,请登录
-
Is venetoclax beneficial in patients with del(17p) CLL? Read our summary of long-term follow-up data from the M13-982 trial here ?? https://loom.ly/VbBerbM #CLL #lymsm
要查看或添加评论,请登录